Enhancing Lung Cancer Screening Through Human-Centered Intervention
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Lung Cancer
- Sponsor
- University of California, Davis
- Enrollment
- 2869
- Locations
- 1
- Primary Endpoint
- Lung Cancer Screening
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The purpose of this study is to further understand the factors involved in increasing lung cancer screening.
Detailed Description
The study aims to identify patient, primary care team and health system factors that facilitate participation in lung cancer screening. Additionally, conduct a two-arm randomized comparative effectiveness intervention study to increase lung cancer screening compared with a usual care control arm and further evaluate the differential impact of the intervention conditions compared to usual care.
Investigators
Moon S. Chen,Jr. PhD,MPH
Principal Investigator
University of California, Davis
Eligibility Criteria
Inclusion Criteria
- •Interviews:
- •UC Davis Health Systems (UCDHS) primary care providers and clinic staff who provide services to patients ages 50-
- •Patients who are eligible for lung cancer screening.
- •Screening Intervention:
- •Patients ages 50-80 who have a history of smoking per review of their electronic medical record and who receive care at the following UCDH ambulatory care clinics: Ellison Ambulatory Care Clinic; Elk Grove; Midtown.
Exclusion Criteria
- •Interviews:
- •Non-consenting patients and patients who do not speak English or Spanish
- •Patients aged 49 and younger
- •Non UCDHS primary care providers and clinic staff
- •Screening Intervention:
- •UCDHS patients who have already received Lung Cancer Screening
- •Patients with existing Cancer diagnosis
Outcomes
Primary Outcomes
Lung Cancer Screening
Time Frame: 156 Weeks
The primary outcome is the proportion of patients aged 50-80 with a history of smoking who receive Lung Cancer Screening during the study period; this outcome will be measured in both intervention groups and the control group.
Secondary Outcomes
- Completion of Interviews with Staff and Patients(156 Weeks)